The ITC should have consulted more the FDA prior to banning the device, say PMI lawyers. Read More
Tags :IQOS
The company will expand its Tanauan facility to accommodate the product line. Read More
The case is part of multi-front patent dispute involving IQOS and RJR's Vuse.Read More
Because device is similar to the previous version, PMI can make the same claims. Read More
Russia and Ukraine are nearly a quarter of firm's HTP volume.Read More
The product may be back on American store shelves in the first half of 2023.Read More
The patent board ruling is the latest twist in a long-running dispute between RAI and PMI. Read More
The launch follows the bladeless product’s initial introduction in Japan. Read More
A patent dispute derails the U.S. rollout of IQOS.Read More
The Biden administration lets stand a ruling that IQOS infringes on BAT patents. Read More
